Prognosis in IgA nephropathy |
| |
Authors: | David PACKHAM |
| |
Affiliation: | Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia |
| |
Abstract: | Summary: IgA nephropathy it is now widely recognized as the most common glomerulonephritis causing end-stage renal failure (ESRF) in many parts of the world. Large series of patients have been analysed in an attempt to identify prognostic clinical and histological features. Increasingly the importance of stage specific analysis of such factors has been reflected in the literature. Such analysis suggests that if therapeutic trials are to be conducted in an attempt to improve prognosis in IgA nephropathy these will need to be organized on a multicentre basis under the auspices of an international organization. |
| |
Keywords: | IgA nephropathy clinical trials prognosis |
|
|